Please assess the completion status of the following clinical trial:

Trial Title: A New Approach for Controlling Hemostasis During Canal Treatment

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients aged between 20 and 60 years~* patients able and willing to sign a consent form,~* single-rooted teeth with necrotic pulp confirmed by electric vitality test~* healthy periodontium~* physiologic sulcus depth (\<3 mm)~* absence of bleeding on probing of the involved teeth.~Exclusion Criteria:~* patients with systemic diseases~* patients using anticoagulants in the last 30 days~* patients using antibiotics in the last 30 days~* patients using anti-inflammatory therapies in the last 30 days~* patients with allergy to sulfur in any form~* pregnancy.~All subjects were informed of the nature and potential risks and benefits of their participation in the study

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- HybenX ® (Type: EXPERIMENTAL): 1 cc of mixture of hydroxybenzenesulfonic acid (37%) and hydroxymethoxybenzene acids (23%), sulfuric acid (28%), and water (12%) for 20 sec
- Control (Type: PLACEBO_COMPARATOR): 5 cc of sterile saline water for 20 sec

Based on this trial design, predict the completion outcome and termination type (if applicable).